Virulence arresting drug discovery by strategies targeting bacterial virulence: Mainly focusing on quorum-sensing interference and biofilm inhibition
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
The rising prevalence of multidrug-resistant pathogens poses a substantial threat to global healthcare systems, demanding urgent therapeutic interventions. Microorganisms exhibit diverse resistance mechanisms against various classes of antibiotics, highlighting the urgent need to discover novel antimicrobial agents for combating bacterial infections. Anti-virulence therapy has emerged as a promising therapeutic strategy that neutralizes pathogens by targeting their virulence determinants. The strategies for screening virulence arresting drugs (VADs) in bacteria represent a multifaceted approach that involves elucidating molecular pathogenesis mechanisms of bacterial pathogenicity, identifying evolutionarily conserved virulence factors across different pathogens, and employing integrated approaches combining in silico prediction with experimental validation. Recent technological advancements have established standardized protocols for effective identification and validation of anti-virulence compounds. This review systematically examines contemporary screening methodologies, primarily focusing on quorum-sensing disruption and biofilm suppression strategies, including in silico screening, activity-based screening with bioassays, in vitro and in vivo models. Additionally, we emphasize the imperative for standardized preclinical validation through physiologically relevant animal models, while proposing framework recommendations for developing next-generation VAD screening platforms. This synthesis not only outlines current best practices but also proposes innovative avenues for future antimicrobial discovery research. • Recent advances in strategies were summarized for screening potential virulence arresting drugs (VADs). • The necessity of validation in animal models through the implementation of standardized procedures was underscored. • Suggestions were put forth regarding the development of models and strategies for the screening of VADs.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Virulence arresting drug discovery by strategies targeting bacterial virulence: Mainly focusing on quorum-sensing interference and biofilm inhibition
- Date Crossref
- 01/12/2025
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Chengdu University pays non établi dans la noticeUniversité ou école supérieure
-
Zhejiang Gongshang University pays non établi dans la noticeUniversité ou école supérieure
-
Hanzhong People's Hospital pays non établi dans la noticeÉtablissement de santé
-
Sichuan Center for Disease Control and Prevention pays non établi dans la noticeOrganisme public
-
Southwest Medical University pays non établi dans la noticeÉtablissement de santé
-
School of Pharmacy Anti-Infective Agent Creation Engineering Research Centre of Sichuan Province pays non établi dans la noticeUniversité ou école supérieure
-
Sichuan Institute for Drug Control (Sichuan Testing Center of Medical Devices) Safety Evaluation Center pays non établi dans la noticeStructure de recherche
-
School of Food Science and Biological Engineering pays non établi dans la noticeUniversité ou école supérieure
-
Langzhong People's Hospital Hepatobiliary Surgery pays non établi dans la noticeÉtablissement de santé
Chengdu University, Zhejiang Gongshang University et Hanzhong People's Hospital, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.